GATC Biotech Plans to Sequence 100,000 Human Genomes by 2014 on PacBio RS and HiSeq 2000 | GenomeWeb

German sequencing service provider GATC Biotech said today it plans to sequence and analyze 100,000 human genomes by 2014 on the Illumina HiSeq 2000 and the Pacific Biosciences RS, which it recently announced it would purchase (IS 8/21/2010).

GATC said the genomes would be sequenced for pharmaceutical and diagnostic firms as well as for academic research.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.